Correlation Between Cue Biopharma and In8bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and In8bio Inc, you can compare the effects of market volatilities on Cue Biopharma and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and In8bio.

Diversification Opportunities for Cue Biopharma and In8bio

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Cue and In8bio is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and In8bio go up and down completely randomly.

Pair Corralation between Cue Biopharma and In8bio

Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the In8bio. In addition to that, Cue Biopharma is 1.05 times more volatile than In8bio Inc. It trades about -0.26 of its total potential returns per unit of risk. In8bio Inc is currently generating about 0.05 per unit of volatility. If you would invest  30.00  in In8bio Inc on August 29, 2024 and sell it today you would earn a total of  1.00  from holding In8bio Inc or generate 3.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cue Biopharma  vs.  In8bio Inc

 Performance 
       Timeline  
Cue Biopharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
In8bio Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days In8bio Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Cue Biopharma and In8bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cue Biopharma and In8bio

The main advantage of trading using opposite Cue Biopharma and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.
The idea behind Cue Biopharma and In8bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges